Full Text (PDF)
Indian Journal of Medical and Health Sciences 10(1):p 49-51, January – June 2023. | DOI: https://doi.org/10.21088/ijmhs.2347.9981.10123.7
Case Report
Elevated CEA Levels in Non-smoker and Non-malignant Condition
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Indian Journal of Medical and Health Sciences 10(1):p 49-51, January – June 2023. | DOI: https://doi.org/10.21088/ijmhs.2347.9981.10123.7
How Cite This Article:
Suresh D.R./Elevated CEA Levels in Non-smoker & Non-malignant Condition/Indian Journal of Medical & Health Sciences. 2023;10(1):49–51.Timeline
Received : December 05, 2022
Accepted : January 03, 2023
Published : June 30, 2023
Abstract
Carcinoembryonic Antigen (CEA) is a non-specific tumor marker often found in the blood. High levels of CEA are commonly associated with the progression of wide range of tumors. It is currently used as a biomarker for malignant tumors of the lung and colon, but due to its limited specificity and clinical implication, it can be used only for monitoring rather than tumor diagnosis.1 Certain non-malignant conditions like diabetes mellitus and gastric disease may also affect the CEA levels. These may be relevant particularly in early stages of colorectal cancers. Hence, elucidating the factors that affect the CEA levels might improve the accuracy and utility of its measurement.
References
- 1. C. Huang, T. Zhan, Y. Liu et al., “Glycomic profi ling of carcinoembryonic antigen isolated from human tumor tissue,” Clinical Proteomics, vol. 12, no. 1, p. 17, 2015.
- 2. Téllez-Avila FI, García-Osogobio SM. [The carcinoembryonic antigen: apropos of an old friend]. Rev Invest Clin. 2005 NovDec;57(6):814-819
- 3. Wang H, Meng AM, Li SH, Zhou XL. A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer. Mol Med Rep. 2017 Jul;16(1):625-630.
- 4. Ozgur Turk. The diagnostic value of tumor markers and endoscopy in patients with gastric disorders. Arch Clin Exp Surg. 2015; 4(2): 74-78 doi: 10.5455/aces.20140531053930
- 5. Iwasaki Y, Arai K, Katayanagi S, Takahashi K, Yamaguchi T, Matsumoto H, et al. Biomarkers for neoplasmas in digestive organs. Gan To Kagaku Ryoho 2004;31:1015-1020.
- 6. Hae Yeon Kang, Eun Kyung Choe, Kyu Joo Park, and Young Lee. Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers. Gastroenterology Research and Practice Volume 2017, Article ID 9858931. https://doi.org/10.1155/2017/9858931.
- 7. De Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
- 8. K. F. Newton, W. Newman, and J. Hill, “Review of biomarkers in colorectal cancer,” Colorectal Disease: The Offi cial Journal of the Association of Coloproctology of Great Britain and Ireland, vol. 14, no. 1, pp. 3–17, 2012.
- 9. B. D. Nicholson, B. Shinkins, I. Pathiraja et al., “Blood CEA levels for detecting recurrent colorectal cancer,” Cochrane Database of Systematic Reviews, vol. 12, no. 12, p. CD011134, 2015.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Suresh D.R./Elevated CEA Levels in Non-smoker & Non-malignant Condition/Indian Journal of Medical & Health Sciences. 2023;10(1):49–51.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| December 05, 2022 | January 03, 2023 | June 30, 2023 |
DOI: https://doi.org/10.21088/ijmhs.2347.9981.10123.7
Keywords
Carcinoembryonic Antigen (CEA)Colorectal Cancer (CRC)GastroduodenitisSearch for Similar Articles
Similar Articles
- Wound Assessment using a Smartphone-based Application: Imitomeasure in Pressure...
- Emerging Pandemic and Silent Killer – Non Aloholic Fatty Liver Disease: A Compr...
- Prenatal and Postnatal Healthcare in Odisha
- Assessment of Diabetic Foot Ulcers: A Review
- IBS – Irritable Bowel Syndrome – Management through Comprehensive Non-Pharmacolo...
Article Level Metrics
Last UpdatedTuesday 07 July 2026, 07:17:18 (IST)
746
Accesses
10
309
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | December 05, 2022 |
| Accepted | January 03, 2023 |
| Published | June 30, 2023 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
